CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
“John is an outstanding leader with a proven track record of building high-performing teams that deliver consistent results.
- “John is an outstanding leader with a proven track record of building high-performing teams that deliver consistent results.
- With extensive experience in the molecular diagnostics and life sciences tools industries, John is the right executive to bring strategic leadership to CareDx to propel the company forward and capitalize on future growth opportunities,” said Michael Goldberg, CareDx Board Chairperson.
- CareDx provides hope to patients and their families that they can live fulfilling lives knowing that we support them at every step of their journey,” said John Hanna, CareDx President and CEO.
- Hanna previously served as Chief Executive Officer of Apton Biosystems, Inc., where he led the development of a high throughput next-generation sequencing (NGS) platform for liquid biopsy and other clinical applications.